Yanagawa Y, Masubuchi Y, Chiba K
Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Iruma, Saitama, Japan.
Immunology. 1998 Dec;95(4):591-4. doi: 10.1046/j.1365-2567.1998.00639.x.
FTY720, a novel immunosuppressant, sequesters circulating mature lymphocytes, especially T cells, within lymph nodes and Peyer's patches by accelerating lymphocyte homing, and thereby causes lymphocyte depletion in the blood. The FTY720-induced acceleration of lymphocyte homing appears to be mediated by lymphocyte homing receptors including CD62L, CD49d/beta7, and CD11a/CD18. In this study, expressions of CD62L, CD49d and CD11a on T cells in the peripheral blood, lymph nodes and Peyer's patches were analysed by flow cytometry in rats given FTY720 (1 mg/kg) orally. FTY720 markedly decreased the number of peripheral blood T cells, while not affecting CD62L, CD49d and CD11a expressions at 1-3 hr after administration. In contrast, both the frequency of CD62L-positive T cells and intensity of CD62L expression on T cells were increased in Peyer's patches but not lymph nodes at 3 hr after administration of FTY720. CD49d and CD11a expressions on T cells were unaffected by FTY720 in both Peyer's patches and lymph nodes at the same point in time. On the other hand, analysis of lymphocyte homing with calcein-labelled lymphocytes and anti-CD62L monoclonal antibody (mAb) confirmed that FTY720 predominantly increased CD62L-dependent lymphocyte homing to Peyer's patches. These findings indicate that FTY720 increases the frequency of CD62L-positive T cells by accelerating CD62L-predominant homing in Peyer's patches.
新型免疫抑制剂FTY720通过加速淋巴细胞归巢,使循环中的成熟淋巴细胞,尤其是T细胞,滞留在淋巴结和派尔集合淋巴结内,从而导致血液中的淋巴细胞减少。FTY720诱导的淋巴细胞归巢加速似乎是由包括CD62L、CD49d/beta7和CD11a/CD18在内的淋巴细胞归巢受体介导的。在本研究中,通过流式细胞术分析了口服FTY720(1mg/kg)的大鼠外周血、淋巴结和派尔集合淋巴结中T细胞上CD62L、CD49d和CD11a的表达。FTY720显著降低了外周血T细胞的数量,而在给药后1-3小时不影响CD62L、CD49d和CD11a的表达。相反,在给予FTY720后3小时,派尔集合淋巴结中CD62L阳性T细胞的频率和T细胞上CD62L的表达强度增加,但淋巴结中未增加。在同一时间点,派尔集合淋巴结和淋巴结中T细胞上的CD49d和CD11a表达均不受FTY720影响。另一方面,用钙黄绿素标记的淋巴细胞和抗CD62L单克隆抗体(mAb)对淋巴细胞归巢进行分析证实,FTY720主要增加了依赖CD62L的淋巴细胞向派尔集合淋巴结的归巢。这些发现表明,FTY720通过加速派尔集合淋巴结中以CD62L为主的归巢,增加了CD62L阳性T细胞的频率。